|
PSIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19819709709645E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15320003441144E-09 |
| Normal-vs-Stage2 |
3.47900000030599E-07 |
| Normal-vs-Stage3 |
3.73400199649154E-11 |
| Normal-vs-Stage4 |
3.76940001434178E-09 |
| Stage1-vs-Stage2 |
2.632000E-01 |
| Stage1-vs-Stage3 |
2.384100E-02 |
| Stage1-vs-Stage4 |
1.328950E-01 |
| Stage2-vs-Stage3 |
6.370400E-01 |
| Stage2-vs-Stage4 |
8.090200E-01 |
| Stage3-vs-Stage4 |
8.216800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24269483592343E-11 |
| Normal-vs-AfricanAmerican |
3.561200E-04 |
| Normal-vs-Asian |
5.66389999999695E-05 |
| Caucasian-vs-AfricanAmerican |
6.832000E-01 |
| Caucasian-vs-Asian |
1.272630E-01 |
| AfricanAmerican-vs-Asian |
5.391400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.68159963520998E-11 |
| Normal-vs-Female |
1.62379998336348E-10 |
| Male-vs-Female |
2.563200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00410000314355E-08 |
| Normal-vs-Age(41-60Yrs) |
1.38470002131186E-09 |
| Normal-vs-Age(61-80Yrs) |
2.1334045641197E-11 |
| Normal-vs-Age(81-100Yrs) |
2.241500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.562200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.576500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.166200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.150200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.456200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.104000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.889800E-02 |
| Classical-VS-Follicular |
7.404100E-04 |
| Classical-VS-Other |
4.726200E-01 |
| Classical-VS-Normal |
9.15270004231417E-09 |
| Tall-VS-Follicular |
5.521400E-01 |
| Tall-VS-Other |
9.015800E-01 |
| Tall-VS-Normal |
5.11410000014756E-07 |
| Follicular-VS-Other |
7.060200E-01 |
| Follicular-VS-Normal |
3.27890048446022E-10 |
| Other-VS-Normal |
7.720700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83969950384721E-10 |
| Normal-vs-N1 |
1.71649999769485E-08 |
| N0-vs-N1 |
5.522400E-01 |
|
|
